{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-096021","form_type":"8-K","ticker":"OCUL","cik":"0001393434","company_name":"OCULAR THERAPEUTIX, INC","filed_at":"2024-09-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.888462+00:00","generated_at":"2026-05-31T06:35:46.279300+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Ocular Therapeutix appoints Donald Notman as COO, retains CFO role","bullets":["Donald Notman, age 65, appointed COO on August 29, 2024; continues as CFO and principal financial and accounting officer.","Notman has served as CFO since September 2017; prior roles include CFO of Thrasos Therapeutics and Managing Director at Leerink Swann.","No arrangements or family relationships with other directors/officers; no related party transactions under Item 404(a)."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-096021","json":"https://secwatch.observer/filing/0001104659-24-096021.json","markdown":"https://secwatch.observer/filing/0001104659-24-096021.md","text":"https://secwatch.observer/filing/0001104659-24-096021.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1393434/000110465924096021/0001104659-24-096021-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1393434/000110465924096021/tm2423106d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T06:35:46.279300+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3f0b546450","claim":"Donald Notman was appointed as Chief Operating Officer at OCULAR THERAPEUTIX, INC.","evidence_excerpt":"On August 29, 2024, the board of directors of Ocular Therapeutix, Inc. (the “Company”) appointed Donald Notman to serve as Chief Operating Officer of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465924096021/0001104659-24-096021-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Operating Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}